By Lívia Honório de Figueiredo
August 9, 2017
Published ANVISA’s new rule relative to the prior consent for the granting of a patent for pharmaceutical products and processes
Valid since August 10 2017 – date of its publication on the Official Federal Gazette – this new rule confirms all the principals and procedures already stated on Normative Instruction Nº 01, from May 31 2017.
In case you need further information on this topic, our legal and technical teams are at your disposal in our offices of Rio de Janeiro, São Paulo and Porto Alegre, as well as the email: mail@kasznarleonardos.com
Last by Lívia Honório de Figueiredo
April 24, 2023
“Brazil: The patent combination conundrum” for LSIPR Magazine
Patents to new medicines usually protect the active ingredient (compound), provided that it is new and inventive. It is also a common … “Brazil: The patent combination conundrum” for LSIPR Magazine
December 28, 2022
BPTO publishes phase IV of the Patent Prosecution Highway (PPH) Program
The Brazilian Patent and Trademark Office (BPTO) published, by means of Ordinance n° 78, dated December 16th 2022, phase IV of the Patent … BPTO publishes phase IV of the Patent Prosecution Highway (PPH) Program
February 14, 2022
Life sciences patent eligibility in Latin America: a guide
Patents are critical to the life sciences industry and often spark intense and heated debate. To be successful, one key strategy that … Life sciences patent eligibility in Latin America: a guide